Innovative Hybrid Compounds Targeting Tuberculosis: Development, Characterization and Bioefficacy Analysis of 6-Substituted-2-Chloroquinoline-3-Carbaldehyde Hydrazide Ester Derivatives. Int. J. Pharm. Sci. Drug Res. 2024, 16 (3), 378-386. https://doi.org/10.25004/IJPSDR.2024.160309.